Liguzinediol注射液的制备及质量控制
Preparation and quality control of liguzinediol injection
分类号:
出版年·卷·期(页码):2014,34 (3):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的:制备liguzinediol注射液,建立其质量控制方法。方法:采用活性炭法去除细菌内毒素,热压灭菌法进行灭菌;采用高效液相色谱法测定其含量及有关物质。结果:用0.05%的活性炭除细菌内毒素,115 ℃热压灭菌30 min;各项检查符合药典规定;liguzinediol浓度在80~160 μg·mL-1浓度范围内线性关系良好,平均回收率为99.65%(n=6),RSD=0.99%;检测限为1.2 ng、定量限为12 ng。结论:Liguzinediol注射液制备工艺简便,质量可控;所建立的含量测定方法重复性好,专属性强,结果准确可靠,为后期中试生产提供参考依据。
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To prepare liguzinediol injection and establish its quality control method. Methods: Bacterial endotoxin was removed with active carbon,then the injection was sterilized by autoclaving;the contents of liguzinediol and related substances were determined by HPLC. Results: Bacterial endotoxin was removed with 0.05%active carbon,the injection was sterilized for 30 minutes at 115 ℃.Each detection was in accordance with Chinese Pharmacopoeia.The linear range was 80-160 μg·mL-1(r= 0.9995)for liguzinediol.The average recovery was 99.5%(n=6).The limits of detection and quantitation were 1.2 ng and 12 ng,respectively. Conclusion: The preparation is controllable and convenient and the method is reliable,reproducible and specific and can provide reference for pilot scale production of liguzinediol in the later stage.
-----参考文献:---------------------------------------------------------------------------------------
[1] Li W, Chen L, Bian HM, et al.Application of 2, 5-dihydroxymethyl-3, 6-dimethylpyrazine and its derivates in pharmacy[P].US, 2012 -April-17
[2] LIU Zheng(刘峥), ZHOU Shu-yuan(周淑媛), LI Wei(李伟), et al.Liguzinediol induced positive inotropic effect in normal isolated rat hearts(Liguzinediol对正常大鼠离体心脏的正性肌力作用)[J].J Chin J New Drugs Clin Rem(中国新药与临床杂志), 2009, 28(4): 293
[3] LIU Zheng(刘峥), BIAN Hui-min(卞慧敏), CHEN Long(陈龙), et al.Effect of liguzinediol on cardiac hemodynamics in healthy rats(Liguzinediol对正常大鼠心脏血流动力学的影响)[J].J Chin Pharm J(中国药学杂志), 2009, 44(15): 1155
[4] GUO Yao(郭瑶), ZHOU Jing(周静), BIAN Hui-min(卞慧敏), et al.The effect of liguzinediol on hemodynamics in rats with acute heart failure induced by pentobarbital(川芎嗪衍生物liguzinediol对戊巴比妥钠致急性心力衰竭大鼠血流动力学的影响)[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2012, 18(6): 170
[5] ZHANG Di-ni(章嫡妮), GUO Yao(郭瑶), LI Zhuo-qiong(李卓琼), et al.Effect of liguzinediol on ventricular remodeling in pressure-overloaded rats(liguzinediol对压力超负荷大鼠心室重构的影响)[J].J Chin Pharm Bull(中国药理学通报), 2012, 28(12): 1699
[6] CHEN Long, XU Yi, LI Wei, et al.The novel compound liguzinediol exerts positive inotropic effects on isolated rat heart via sarcoplasmic reticulum Ca2+ ATPase-dependent mechanism[J].Life Sci, 2012, 91:402
[7] Larissa L, Elie RC, Lahouaria H, et al.Sarcoplasmic reticulum Ca2+ATPase as a therapeutic target for heart failure[J].Expert Opin Biol Ther, 2010, 10(1): 29
[8] XU Yi(徐毅), LUO Zhuo-ka(罗卓卡), LIU Quan-ming(刘泉明), et al.Positive inotropic mechanism of liguzinediol and heart safety evaluation(Liguzinediol的正性肌力作用机制及心脏安全性)[J].Chin J Pharmacol Toxicol(中国药理学与毒理学杂志), 2012, 26(2): 151
[9] WEN Kan(闻侃), LIU Zheng(刘峥), BIAN Hui-min(卞慧敏), et al.Acute toxicity of liguzinediol(liguzinediol的急性毒性)[J].J Chin J New Drugs Clin Rem(中国新药与临床杂志), 2011, 30(3): 234
[10] SHAN Chen-xiao(单晨啸), LI Wei(李伟), WEN Hong-mei(文红梅), et al.Determination of liguzinediol and its pharmacokinetics in rat by ultra performance of liquid chromatography(UPLC法测定大鼠血浆中Liguzinediol浓度以及动力学研究)[J].J Chin Pharm Bull(中国药理学通报), 2011, 27(5): 709
[11] JU Rui-jun(居瑞军), LI Ruo-jing(李若婧), ZHOU Peng(周鹏), et al.Preparation of salidroside injection and its pharmacokinetics in rats(红景天苷注射剂的制备及其在大鼠体内药动学研究)[J].Chin Pharm J(中国药学杂志), 2012, 47(18): 1497
[12] FANG Min(房敏), LI Wei(李伟), WEN Hong-mei(文红梅), et al.HPLC determination of liguzinediol and its related substances(HPLC法测定Liguzinediol原料药的含量及有关物质)[J].J Nanjing Univ Tradit Chin Med(南京中医药大学学报), 2012, 28(3): 279
欢迎阅读《药物分析杂志》!您是该文第 948位读者!